InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Foghorn Therapeutics Inc.

FHTX Clue Score52
United States Fiscal year ends December CIK 0001822462
$1.95 -2.50% Close, 12 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.95 −84.21% Close, 12 Oct 2026

Closing prices at the end of each trading day, from 23 Oct 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2019Operating income−51.1Net income−51.1Fiscal year 2020Revenue0.4Operating income−68.5Net income−68.8EPS, diluted−6.23Fiscal year 2021Revenue1.3 +206.7%Operating income−100.7Net income−101.3EPS, diluted−2.73Fiscal year 2022Revenue19.2 +1,357.8%Operating income−117.1Net income−108.9EPS, diluted−2.62Fiscal year 2023Revenue34.2 +77.6%Operating income−107.9Net income−98.4EPS, diluted−2.34Fiscal year 2024Revenue22.6 −33.8%Operating income−102.7Net income−86.6EPS, diluted−1.58Fiscal year 2025Revenue30.9 +36.8%Operating income−86.4Net income−74.3EPS, diluted−1.18
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 0.4 1.3 19.2 34.2 22.6 30.9
Growth +206.7% +1,357.8% +77.6% −33.8% +36.8%
Operating income −51.1 −68.5 −100.7 −117.1 −107.9 −102.7 −86.4
Net income −51.1 −68.8 −101.3 −108.9 −98.4 −86.6 −74.3
Growth
EPS, diluted n/a −6.23 −2.73 −2.62 −2.34 −1.58 −1.18

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2019Fiscal year 2020Operating margin−15,937.4%Net margin−16,000.0%Free cash flow margin−11,039.3%Fiscal year 2021Operating margin−7,637.1%Net margin−7,681.6%Free cash flow margin−4,060.9%Fiscal year 2022Operating margin−609.2%Net margin−566.3%Free cash flow margin1,000.6%Fiscal year 2023Operating margin−315.9%Net margin−288.2%Free cash flow margin−349.4%Fiscal year 2024Operating margin−454.3%Net margin−383.2%Free cash flow margin−448.2%Fiscal year 2025Operating margin−279.5%Net margin−240.3%Free cash flow margin−278.7%
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −15,937.4% −7,637.1% −609.2% −315.9% −454.3% −279.5%
Net margin n/a −16,000.0% −7,681.6% −566.3% −288.2% −383.2% −240.3%
Free cash flow margin n/a −11,039.3% −4,060.9% 1,000.6% −349.4% −448.2% −278.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2019Operating cash flow−46.3Capital expenditure−1.0Free cash flow−47.3Fiscal year 2020Operating cash flow−31.3Capital expenditure−16.2Free cash flow−47.5Fiscal year 2021Operating cash flow−50.3Capital expenditure−3.3Free cash flow−53.6Fiscal year 2022Operating cash flow193.6Capital expenditure−1.2Free cash flow192.4Fiscal year 2023Operating cash flow−118.1Capital expenditure−1.2Free cash flow−119.3 −162.0%Fiscal year 2024Operating cash flow−100.4Capital expenditure−0.9Free cash flow−101.3Fiscal year 2025Operating cash flow−86.1Capital expenditure−0.1Free cash flow−86.1
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −46.3 −31.3 −50.3 193.6 −118.1 −100.4 −86.1
Capital expenditure −1.0 −16.2 −3.3 −1.2 −1.2 −0.9 −0.1
Free cash flow −47.3 −47.5 −53.6 192.4 −119.3 −101.3 −86.1
Growth −162.0%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2019Cash15.0Total debt15.1Net cash (debt)−0.1Shareholders’ equity−88.0Fiscal year 2020Cash92.8Total debt19.7Net cash (debt)73.1Shareholders’ equity146.2Debt to equity0.13Fiscal year 2021Cash101.1Total debt0.0Net cash (debt)101.1Shareholders’ equity96.9Debt to equity0.00Fiscal year 2022Cash52.2Shareholders’ equity0.1Fiscal year 2023Cash80.3Shareholders’ equity−77.2Fiscal year 2024Cash55.5Shareholders’ equity−45.5Fiscal year 2025Cash80.9Shareholders’ equity−108.5
FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 15.0 92.8 101.1 52.2 80.3 55.5 80.9
Total debt 15.1 19.7 0.0 n/a n/a n/a n/a
Net cash (debt) −0.1 73.1 101.1 n/a n/a n/a n/a
Shareholders’ equity −88.0 146.2 96.9 0.1 −77.2 −45.5 −108.5
Debt to equity n/a 0.13 0.00 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021† 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 0.4 1.3 19.2 34.2 22.6 30.9
Growth +206.7% +1,357.8% +77.6% −33.8% +36.8%
44.4 57.7 80.3 105.6 109.7 94.5 85.5
6.7 11.2 21.7 30.7 32.4 28.4 27.6
−51.1 −68.5 −100.7 −117.1 −107.9 −102.7 −86.4
Growth
n/a n/a n/a −108.9 −94.2 −86.6 n/a
0.0 0.0 n/a 0.0 4.2 0.0 0.0
−51.1 −68.8 −101.3 −108.9 −98.4 −86.6 −74.3
Growth
Per share
n/a −6.23 −2.73 −2.62 −2.34 −1.58 −1.18
n/a −6.23 −2.73 −2.62 −2.34 −1.58 −1.18
Growth
n/a 11.0 37.2 41.6 42.0 54.9 63.0
n/a 11.0 37.2 41.6 42.0 54.9 63.0
Growth +236.5% +11.9% +0.9% +30.8% +14.7%

† The diluted share count jumps at 2021, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 135.1% a year over five years.
  • Operating margin is up 15,657.9 points on five years ago, at -279.5%.
  • A net loss in 7 of 7 years on file.